Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Melanoma acral en población caucásica, Estudio de cohorte sobre factores epidemiológicos, clinicopatológicos y pronósticos, Acral Melanoma in the Caucasian Population

  • Angel-Baldo, J.
  • Podlipnik, Sebastian|||0000-0003-4150-0522
  • Azón, A.
  • Boada, Aram|||0000-0001-9809-5308
  • Arrieta, A.
  • Marcoval, Joaquim|||0000-0002-6489-1872
  • López Sánchez, Cristina|||0000-0003-1866-6989
  • Sàbat, M.
  • Segura, S.
  • Bodet, D.
  • Curcó, N.
  • Lopez-Castillo, D.
  • Solà, J.
  • Quintana-Codina, M.
  • Baliu-Piqué, C.
  • Just Sarobé, Miquel|||0000-0002-9649-9250
  • Martín-Sala, S.
  • Malvehy, J.
  • Puig, Susana|||0000-0003-1337-9745
  • Carrera, Caty|||0000-0002-0804-0969
  • Marti, R.M.
  • Matas-Nadal, C.
  • Soria-Gili, Xavier
  • Gatius, S.
  • Vilardell, Felip
  • Gil, I.
  • Grau, C.
  • Martínez, F.
  • Lobos, N.
  • Yélamos, Oriol|||0000-0002-8058-3095
  • Dalmau, J.
  • González-Cruz, C.|||0000-0003-0117-8858
  • Hilari, H.
  • Pasquali, P.
  • Sagristà, M.
  • Olivella-Garcés, M.R.
  • Bonfill-Ortí, Montserrat
  • Ramón Ferreres, J.
  • Jaka, A.
  • Quer, A.
  • Richarz, N.
  • Zarzoso Muñoz, I.
  • Zaballos, Pedro
  • Formigon, M.
  • Galvany, L.
  • Alegre, M.
  • Sánchez-Puigdollers, A.
  • Mohino-Farré, N.
  • Masferrer, E.
Introducción: El melanoma acral está asociado con un pronóstico desfavorable. El estudio sobre las características y el pronóstico en los pacientes caucásicos puede ser crucial para comprender las características distintivas de este tumor. Objetivos: Analizar las características epidemiológicas, clinicopatológicas y pronósticas del melanoma acral en los pacientes caucásicos. Material y métodos: Estudio de cohorte retrospectivo de melanoma acral a partir de una base de datos multi-institucional en 20 hospitales españoles, entre enero de 2000 y diciembre de 2019. Resultados: Se identificaron un total de 733 melanomas acrales (edad media: 67,5 años, el 95,2% caucásicos y el 77,5% en los pies). En general, el 77,5% de los casos fueron invasivos. Los melanomas localizados en los pies tuvieron una mayor proporción de casos invasivos (80,8 vs. 69,8%; p = 0,003), estadios III y IV al diagnóstico (24,8 vs. 11,7%; p < 0,001), valores de Breslow más altos (2,8 vs. 2,0 mm; p = 0,021) y una mayor tasa de positividad de biopsia selectiva del ganglio centinela (BSGC) (30,7 vs. 15,7%; p = 0,012). Un mayor grosor de Breslow y una edad de aparición más tardía fueron factores de riesgo para menor supervivencia específica por melanoma. Un mayor grosor de Breslow y la ulceración fueron los factores pronósticos independientes menor supervivencia libre de recaída. La localización del melanoma y el subtipo histopatológico no se asociaron con un peor pronóstico. Las recurrencias fueron frecuentes (27,7%), con a distancia apareciendo antes que las recurrencias locorregionales (1,32 años [IQR: 1,12-1,87] vs. 2,14 años [IQR: 1,68-2,70]; p = 0,015). Conclusión: Este estudio, el mayor en una población predominantemente caucásica, subraya los resultados desfavorables del melanoma acral. Los melanomas en los pies mostraron una detección tardía, mayor proporción de melanomas invasivos, valores de Breslow más profundos, mayor positividad o afectación de BSGC y estadios AJCC más altos. La alta tasa de recurrencia y las metástasis a distancia tempranas enfatizan el papel crítico del seguimiento intensivo y las pruebas de imagen rutinarias para detectar recaídas asintomáticas., Background: Acral melanoma is associated with poor prognosis. Studying the characteristics and prognosis of Caucasian patients is crucial to understand the distinct features of this tumor. Objectives: To analyze the epidemiological, clinicopathological, and prognostic features of acral melanoma in Caucasian patients. Methods: We conducted a retrospective, multicenter, cohort study of acral melanoma from a database across 20 hospitals from South Europe from January 2000 to December 2019. Results: A total of 733 acral melanomas were identified (median age, 67.5 years; 95.2%, Caucasians; 77.5% of which were located on the feet). Overall, 77.5% of cases were invasive melanomas. Foot melanomas had a higher proportion of invasive cases (80.8% vs 69.8%; p = 0.003), stages III and IV at diagnosis (24.8% vs 11.7%; p < 0.001), thicker Breslow depth (2.8 mm vs 2.0 mm; p = 0.021) and a higher rate of positive sentinel lymph node biopsy (SLNB) (30.7% vs 15.7%; p = 0.012). Thicker Breslow depth and later age of onset were risk factors for melanoma-specific survival. Thicker Breslow depth and ulceration were independent prognostic factors of relapse-free survival. Melanoma location and histopathological subtype were not associated with worse prognosis. Recurrences were a common finding (27.7%), with distant metastases appearing earlier than locoregional recurrences (1.32 years [IQR, 1.12-1.87] vs 2.14 years [IQR, 1.68-2.70]; p = 0.015). Conclusion: This study, the largest in a predominantly Caucasian population, underscores the unfavorable outcomes of acral melanoma. Foot melanomas exhibited delayed detection, increased invasiveness, thicker Breslow depth, increased SLNB involvement, and higher AJCC stages. The high recurrence rate and early distant metastases emphasize the critical role of intensive follow-up and routine imaging modalities to detect asymptomatic relapses.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Quantitative analysis of somatically acquired and constitutive uniparental disomy in gastrointestinal cancers

  • Torabi Asensio, Keyvan|||0000-0002-9067-0061
  • Erola, Pau
  • Álvarez Mora, María Isabel|||0000-0003-3788-8915
  • Díaz-Gay, Marcos|||0000-0003-0658-0467
  • Ferrer Menduiña, Queralt|||0000-0003-3177-4618
  • Castells, Antoni|||0000-0001-8431-2033
  • Castellví-Bel, Sergi|||0000-0003-1217-5097
  • Milà, Montserrat
  • Lozano, Juan José
  • Miró Ametller, Rosa|||0000-0003-2508-5074
  • Ried, Thomas|||0000-0002-0767-6009
  • Ponsa Arjona, Immaculada|||0000-0003-3436-1907
  • Camps Polo, Jordi|||0000-0003-2929-4228
Somatically acquired uniparental disomies (aUPDs) are frequent events in solid tumors and have been associated with cancer-related genes. Studies assessing their functional consequences across several cancer types are therefore necessary. Here, we aimed at integrating aUPD profiles with the mutational status of cancer-related genes in a tumor-type specific manner. Using TCGA datasets for 1,032 gastrointestinal cancers, including colon (COAD), rectum (READ), stomach (STAD), esophageal adenocarcinoma (EAC) and esophageal squamous cell carcinoma (ESCC), we show a non-random distribution of aUPD, suggesting the existence of a cancer-specific landscape of aUPD events. Our analysis indicates that aUPD acts as a "second hit" in Knudson's model in order to achieve biallelic inactivation of tumor suppressor genes. In particular, APC , ARID1A and NOTCH1 were recurrently inactivated by the presence of homozygous mutation as a consequence of aUPD in COAD and READ, STAD and ESCC, respectively. Furthermore, while TP53 showed inactivation caused by aUPD at chromosome arm 17p across all tumor types, copy number losses at this genomic position were also frequent. By experimental and computationally inferring genome ploidy, we demonstrate that an increased number of aUPD events, both affecting the whole chromosome or segments of it, were present in highly aneuploid genomes compared to near-diploid tumors. Finally, the presence of mosaic UPD was detected at a higher frequency in DNA extracted from peripheral blood lymphocytes of patients with colorectal cancer compared to healthy individuals. In summary, our study defines specific profiles of aUPD in gastrointestinal cancers and provides unequivocal evidence of their relevance in cancer.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Incidence of Melanoma in Catalonia, Spain, Is Rapidly Increasing in the Elderly Population. A Multicentric Cohort Study

  • Podlipnik, Sebastian|||0000-0003-4150-0522
  • Carrera, Cristina|||0000-0003-1608-8820
  • Boada, Aram|||0000-0001-9809-5308
  • Richarz, Nina
  • Marcoval, Joaquim|||0000-0002-6489-1872
  • Ferreres, Josep Ramón
  • Bodet, Domingo|||0000-0003-2227-0696
  • Martí, Rosa María|||0000-0001-6866-6114
  • Segura, Sonia|||0000-0003-0653-1382
  • Sabat Santandreu, Mireia|||0000-0003-2583-5138
  • Dalmau-Arias, Joan
  • Quintana, Mònica
  • Azon, Antoni|||0000-0003-3112-552X
  • Curcó, Neus
  • Formigon, Manel
  • Olivella-Garcés, María Rosa
  • Zaballos, Pedro
  • Sola, Joaquim
  • Galvany, Loida
  • Baliu-Piqué, Carola
  • Alegre Fernández, Marta|||0000-0003-4718-4831
  • Pasquali, Paola
  • Malvehy, Josep|||0000-0002-6998-914X
  • Puig, Susana|||0000-0003-1337-9745
The incidence of melanoma has been increasing worldwide during recent decades. The objective of the study was to analyse the trends in incidence for in situ and invasive melanoma in the Spanish region of Catalonia during the period of 2008-2017. We designed a cross-sectional study with an age-period-cohort analysis of melanoma patient data from the Network of Melanoma Centres in Catalonia. Our database covered a population of over seven million and included a total of 8626 patients with incident melanoma. The main outcome measures were crude and age-standardised incidence rates to the European 2013 standard population. Joinpoint regression models were used to evaluate the population trends. We observed an increase in the age-standardised incidence rate (per 100,000 population) of all melanoma subtypes from 11.56 in 2008 to 13.78 in 2017 with an average annual percent change (AAPC) of 3.5%. This incidence increase was seen exclusively in the older population. Moreover, the stratified analysis showed a statistically significant increase in the age-standardised incidence rate for invasive (AAPC 2.1%) and in situ melanoma (AAPC 6.5%). In conclusion, the incidence of melanoma has continued to increase in the elderly population over recent decades, with a rapidly increasing trend of in situ melanomas and the lentigo maligna subtype.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Evaluation of AQP4 functional variants and its association with fragile X-associated tremor/ataxia syndrome

  • Elias-Mas, Andrea
  • Potrony, Miriam|||0000-0003-2766-0765
  • Bague, Jaume
  • Cutler, David J.
  • Álvarez Mora, María Isabel|||0000-0003-3788-8915
  • Torres, Teresa
  • Barcos, Tamara
  • Puig-Butille, Joan Anton
  • Rubio, Marta
  • Madrigal, Irene|||0000-0002-7229-1199
  • Puig, Susana|||0000-0003-1337-9745
  • Allen, Emily G.
  • Rodriguez-Revenga, Laia|||0000-0002-6332-3929
Fragile X-associated tremor/ataxia syndrome (FXTAS, OMIM# 300623) is a late-onset neurodegenerative disorder with reduced penetrance that appears in adult FMR1 premutation carriers (55-200 CGGs). Clinical symptoms in FXTAS patients usually begin with an action tremor. After that, different findings including ataxia, and more variably, loss of sensation in the distal lower extremities and autonomic dysfunction, may occur, and gradually progress. Cognitive deficits are also observed, and include memory problems and executive function deficits, with a gradual progression to dementia in some individuals. Aquaporin 4 (AQP4) is a commonly distributed water channel in astrocytes of the central nervous system. Changes in AQP4 activity and expression have been implicated in several central nervous system disorders. Previous studies have suggested the associations of AQP4 single nucleotide polymorphisms (SNPs) with brain-water homeostasis, and neurodegeneration disease. To date, this association has not been studied in FXTAS. To investigate the association of AQP4 SNPs with the risk of presenting FXTAS, a total of seven common AQP4 SNPs were selected and genotyped in 95 FMR1 premutation carriers with FXTAS and in 65 FMR1 premutation carriers without FXTAS. The frequency of AQP4 -haplotype was compared between groups, denoting 26 heterozygous individuals and 5 homozygotes as carriers of the minor allele in the FXTAS group and 25 heterozygous and 2 homozygotes in the no-FXTAS group. Statistical analyses showed no significant associations between AQP4 SNPs/haplotypes and development of FXTAS. Although AQP4 has been implicated in a wide range of brain disorders, its involvement in FXTAS remains unclear. The identification of novel genetic markers predisposing to FXTAS or modulating disease progression is critical for future research involving predictors and treatments.